Keith W Pfeil
Pengajuan SEC Pertama: 26 Agu 2019 · Terbaru: 26 Agu 2019
Orang Dalam di
Transaksi orang dalam
Perubahan harga vs kuotasi saat ini, disesuaikan split untuk aksi korporasi sejak pengajuan — tidak dibenchmark, tidak diannualisasi, tidak dibobot berdasarkan ukuran
| Tanggal | Ticker | Kode | Saham | Harga | Nilai | Dimiliki setelah | Δ milik | A/D | vs sekarang |
|---|---|---|---|---|---|---|---|---|---|
| 21 Jan. 2026 | GMED | A | 100.000 | · | · | 100.000 Langsung | · | Diakuisisi | (harga per 2026-10-02) |
| 18 Juli 2025 | GMED | A | 40.000 | · | · | 40.000 Langsung | · | Diakuisisi | (harga per 2026-10-02) |
| 23 Jan. 2025 | GMED | A | 60.000 | · | · | 60.000 Langsung | · | Diakuisisi | (harga per 2026-10-02) |
| 10 Jan. 2025 | GMED | M | 8.334 | · | · | 833 Langsung | -90,91% | Dilepas | (harga per 2026-10-02) |
| 10 Jan. 2025 | GMED | M | 5.833 | · | · | 0 Langsung | -100,00% | Dilepas | (harga per 2026-10-02) |
| 10 Jan. 2025 | GMED | S 10b5-1 | 1.666 | $89,17 | $148.557 | 0 Langsung | -100,00% | Dilepas | -15,2% (harga per 2026-10-02) |
| 10 Jan. 2025 | GMED | S 10b5-1 | 12.501 | $88,17 | $1.102.213 | 1.666 Langsung | -88,24% | Dilepas | -14,3% (harga per 2026-10-02) |
| 10 Jan. 2025 | GMED | M | 8.334 | $53,27 | $443.952 | 14.167 Langsung | +142,88% | Diakuisisi | 41,9% (harga per 2026-10-02) |
| 10 Jan. 2025 | GMED | M | 5.833 | $49,65 | $289.608 | 5.833 Langsung | · | Diakuisisi | 52,3% (harga per 2026-10-02) |
| 26 Jan. 2024 | GMED | A | 60.000 | · | · | 60.000 Langsung | · | Diakuisisi | (harga per 2026-10-02) |
| 10 Okt. 2023 | GMED | A | 5.000 | · | · | 5.000 Langsung | · | Diakuisisi | (harga per 2026-10-02) |
| 2 Feb. 2023 | GMED | M | 15.000 | · | · | 9.167 Langsung | -62,07% | Dilepas | (harga per 2026-10-02) |
| 2 Feb. 2023 | GMED | M | 14.167 | · | · | 5.833 Langsung | -70,84% | Dilepas | (harga per 2026-10-02) |
| 2 Feb. 2023 | GMED | S 10b5-1 | 29.167 | $77,57 | $2.262.484 | 0 Langsung | -100,00% | Dilepas | -2,5% (harga per 2026-10-02) |
| 2 Feb. 2023 | GMED | M | 15.000 | $53,27 | $799.050 | 29.167 Langsung | +105,88% | Diakuisisi | 41,9% (harga per 2026-10-02) |
| 2 Feb. 2023 | GMED | M | 14.167 | $49,65 | $703.392 | 14.167 Langsung | · | Diakuisisi | 52,3% (harga per 2026-10-02) |
| 26 Jan. 2023 | GMED | A | 40.000 | · | · | 40.000 Langsung | · | Diakuisisi | (harga per 2026-10-02) |
| 27 Jan. 2022 | GMED | A | 40.000 | · | · | 40.000 Langsung | · | Diakuisisi | (harga per 2026-10-02) |
| 19 Agu 2021 | GMED | M | 0 | · | · | 24.167 Langsung | 0,00% | Dilepas | (harga per 2026-10-02) |
| 19 Agu 2021 | GMED | M | 833 | · | · | 20.000 Langsung | -4,00% | Dilepas | (harga per 2026-10-02) |
| 19 Agu 2021 | GMED | S 10b5-1 | 833 | $76,13 | $63.416 | 0 Langsung | -100,00% | Dilepas | -0,7% (harga per 2026-10-02) |
| 19 Agu 2021 | GMED | M | 833 | $49,65 | $41.358 | 833 Langsung | · | Diakuisisi | 52,3% (harga per 2026-10-02) |
| 19 Agu 2021 | GMED | M | 833 | · | · | 23.334 Langsung | -3,45% | Dilepas | (harga per 2026-10-02) |
| 19 Agu 2021 | GMED | S 10b5-1 | 833 | $76,13 | $63.416 | 0 Langsung | -100,00% | Dilepas | -0,7% (harga per 2026-10-02) |
| 19 Agu 2021 | GMED | M | 833 | $53,27 | $44.374 | 833 Langsung | · | Diakuisisi | 41,9% (harga per 2026-10-02) |
| 2 Agu 2021 | GMED | M | 833 | · | · | 24.167 Langsung | -3,33% | Dilepas | (harga per 2026-10-02) |
| 2 Agu 2021 | GMED | S 10b5-1 | 833 | $83,24 | $69.339 | 0 Langsung | -100,00% | Dilepas | -9,2% (harga per 2026-10-02) |
| 2 Agu 2021 | GMED | M | 833 | $53,27 | $44.374 | 833 Langsung | · | Diakuisisi | 41,9% (harga per 2026-10-02) |
| 19 Juli 2021 | GMED | M | 834 | · | · | 20.833 Langsung | -3,85% | Dilepas | (harga per 2026-10-02) |
| 19 Juli 2021 | GMED | S 10b5-1 | 834 | $78,25 | $65.260 | 0 Langsung | -100,00% | Dilepas | -3,4% (harga per 2026-10-02) |
| 19 Juli 2021 | GMED | M | 834 | $49,65 | $41.408 | 834 Langsung | · | Diakuisisi | 52,3% (harga per 2026-10-02) |
| 1 Juli 2021 | GMED | M | 833 | · | · | 25.000 Langsung | -3,22% | Dilepas | (harga per 2026-10-02) |
| 1 Juli 2021 | GMED | S 10b5-1 | 833 | $77,43 | $64.499 | 0 Langsung | -100,00% | Dilepas | -2,4% (harga per 2026-10-02) |
| 1 Juli 2021 | GMED | M | 833 | $53,27 | $44.374 | 833 Langsung | · | Diakuisisi | 41,9% (harga per 2026-10-02) |
| 25 Juni 2021 | GMED | M | 14.167 | $53,27 | $754.676 | 14.167 Langsung | · | Diakuisisi | 41,9% (harga per 2026-10-02) |
| 25 Juni 2021 | GMED | S 10b5-1 | 27.479 | $75,04 | $2.062.024 | 0 Langsung | -100,00% | Dilepas | 0,7% (harga per 2026-10-02) |
| 25 Juni 2021 | GMED | M | 14.167 | · | · | 25.833 Langsung | -35,42% | Dilepas | (harga per 2026-10-02) |
| 25 Juni 2021 | GMED | M | 13.312 | · | · | 21.667 Langsung | -38,06% | Dilepas | (harga per 2026-10-02) |
| 25 Juni 2021 | GMED | M | 13.312 | $49,65 | $660.941 | 13.312 Langsung | · | Diakuisisi | 52,3% (harga per 2026-10-02) |
| 5 Mei 2021 | GMED | M | 5.021 | · | · | 34.979 Langsung | -12,55% | Dilepas | (harga per 2026-10-02) |
| 5 Mei 2021 | GMED | S 10b5-1 | 5.021 | $75,00 | $376.575 | 0 Langsung | -100,00% | Dilepas | 0,8% (harga per 2026-10-02) |
| 5 Mei 2021 | GMED | M | 5.021 | $49,65 | $249.293 | 5.021 Langsung | · | Diakuisisi | 52,3% (harga per 2026-10-02) |
| 14 Jan. 2021 | GMED | A | 40.000 | · | · | 40.000 Langsung | · | Diakuisisi | (harga per 2026-10-02) |
| 22 Jan. 2020 | GMED | A | 40.000 | · | · | 40.000 Langsung | · | Diakuisisi | (harga per 2026-10-02) |
| 3 Sep. 2019 | GMED | A | 40.000 | · | · | 40.000 Langsung | · | Diakuisisi | (harga per 2026-10-02) |
P = Pembelian pasar terbuka · S = Penjualan · A = Hibah/penghargaan · B = Pelaksanaan opsi · G = Hadiah · F = Pemotongan pajak
Transaksi orang dalam bukan merupakan rekomendasi; penjualan sering kali didorong oleh alasan likuiditas atau pajak.
Kepemilikan Derivatif (Formulir 4 Tabel II) Opsi, RSU, dan sekuritas konversi yang dilaporkan pada Formulir 4 Tabel II.
| Tanggal | Ticker | Sekuritas | Underlying | Harga Pelaksanaan | Kedaluwarsa | Saham | A/D |
|---|---|---|---|---|---|---|---|
| 21 Jan. 2026 | GMED | Stock Option (Right to Buy Class A Common Stock) | Class A Common Stock | $94,15 | 21 Jan. 2036 | 100.000 | Diakuisisi |
| 18 Juli 2025 | GMED | Stock Option (Right to Buy Class A Common Stock) | Class A Common Stock | $56,34 | 18 Juli 2035 | 40.000 | Diakuisisi |
| 23 Jan. 2025 | GMED | Stock Option (Right to Buy Class A Common Stock) | Class A Common Stock | $92,42 | 23 Jan. 2035 | 60.000 | Diakuisisi |
| 10 Jan. 2025 | GMED | Stock Option (Right to Buy Class A Common Stock) | Class A Common Stock | $53,27 | 22 Jan. 2030 | 8.334 | Dilepas |
| 10 Jan. 2025 | GMED | Stock Option (Right to Buy Class A Common Stock) | Class A Common Stock | $49,65 | 3 Sep. 2029 | 5.833 | Dilepas |
| 26 Jan. 2024 | GMED | Stock Option (Right to Buy Class A Common Stock) | Class A Common Stock | $53,75 | 26 Jan. 2034 | 60.000 | Diakuisisi |
| 10 Okt. 2023 | GMED | Stock Option (Right to Buy Class A Common Stock) | Class A Common Stock | $53,02 | 1 Sep. 2033 | 5.000 | Diakuisisi |
| 2 Feb. 2023 | GMED | Stock Option (Right to Buy Class A Common Stock) | Class A Common Stock | $53,27 | 22 Jan. 2030 | 15.000 | Dilepas |
| 2 Feb. 2023 | GMED | Stock Option (Right to Buy Class A Common Stock) | Class A Common Stock | $49,65 | 3 Sep. 2029 | 14.167 | Dilepas |
| 26 Jan. 2023 | GMED | Stock Option (Right to Buy Class A Common Stock) | Class A Common Stock | $75,18 | 26 Jan. 2033 | 40.000 | Diakuisisi |
| 27 Jan. 2022 | GMED | Stock Option (Right to Buy Class A Common Stock) | Class A Common Stock | $63,68 | 27 Jan. 2032 | 40.000 | Diakuisisi |
| 19 Agu 2021 | GMED | Stock Option (Right to Buy Class A Common Stock) | Class A Common Stock | $53,27 | 22 Jan. 2030 | 0 | Dilepas |
| 19 Agu 2021 | GMED | Stock Option (Right to Buy Class A Common Stock) | Class A Common Stock | · | 3 Sep. 2029 | 833 | Dilepas |
| 19 Agu 2021 | GMED | Stock Option (Right to Buy Class A Common Stock) | Class A Common Stock | $53,27 | 22 Jan. 2030 | 833 | Dilepas |
| 2 Agu 2021 | GMED | Stock Option (Right to Buy Class A Common Stock) | Class A Common Stock | $53,27 | 22 Jan. 2030 | 833 | Dilepas |
| 19 Juli 2021 | GMED | Stock Option (Right to Buy Class A Common Stock) | Class A Common Stock | $49,65 | 3 Sep. 2029 | 834 | Dilepas |
| 1 Juli 2021 | GMED | Stock Option (Right to Buy Class A Common Stock) | Class A Common Stock | $53,27 | 22 Jan. 2030 | 833 | Dilepas |
| 25 Juni 2021 | GMED | Stock Option (Right to Buy Class A Common Stock) | Class A Common Stock | $53,27 | 22 Jan. 2030 | 14.167 | Dilepas |
| 25 Juni 2021 | GMED | Stock Option (Right to Buy Class A Common Stock) | Class A Common Stock | $49,65 | 3 Sep. 2029 | 13.312 | Dilepas |
| 5 Mei 2021 | GMED | Stock Option (Right to Buy Class A Common Stock) | Class A Common Stock | $49,65 | 3 Sep. 2029 | 5.021 | Dilepas |
| 14 Jan. 2021 | GMED | Stock Option (Right to Buy Class A Common Stock) | Class A Common Stock | $65,05 | 14 Jan. 2031 | 40.000 | Diakuisisi |
| 22 Jan. 2020 | GMED | Stock Option (Right to Buy Class A Common Stock) | Class A Common Stock | $53,27 | 22 Jan. 2030 | 40.000 | Diakuisisi |
| 3 Sep. 2019 | GMED | Stock Option (Right to Buy Class A Common Stock) | Class A Common Stock | $49,65 | 3 Sep. 2029 | 40.000 | Diakuisisi |
Harga pelaksanaan/konversi kosong jika tidak berlaku (misalnya, RSU).
Kepemilikan Awal (Formulir 3) 1 saham
Sekuritas yang dipegang saat pertama kali menjadi orang dalam, sesuai Formulir 3 SEC.
| Tanggal | Ticker | Sekuritas | Saham | Kepemilikan |
|---|---|---|---|---|
| 26 Agu 2019 | GMED | No securities are beneficially owned | 0 | Langsung |
Kompensasi (DEF 14A)
Dicocokkan berdasarkan nama dari pernyataan proksi (DEF 14A) — verifikasi terhadap pengajuan.
| Tahun fiskal | Gaji | Bonus | Penghargaan saham | Penghargaan opsi | Insentif non-ekuitas | Perubahan Pensiun | Lainnya | Total |
|---|---|---|---|---|---|---|---|---|
| 2025 | $479.467 | $117.000 | · | · | $783.000 | · | $38.345 | $4.400.159 |
| 2024 | $463.555 | · | · | $1.258.665 | $605.454 | · | $35.604 | $2.363.278 |
| 2023 | $414.690 | $100.000 | · | $1.179.403 | $336.375 | · | $32.980 | $2.063.448 |
Angka-angka dari Tabel Kompensasi Ringkasan dalam pernyataan proksi perusahaan (DEF 14A). Kompensasi bukan merupakan rekomendasi.